Cas:910442-12-5 2,9-diazaspiro[5.5]undecan-1-one manufacturer & supplier

Chemical Name:2,9-diazaspiro[5.5]undecan-1-one

CAS.NO:910442-12-5

Synonyms:2,9-diazaspiro[5.5]undecan-1-one

Molecular Formula:C₉H₁₆N₂O

Molecular Weight:168.23600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:369.8ºC at 760 mmHg

Density:1.09g/cm3

Index of Refraction:1.526

PSA:44.62000

Exact Mass:168.12600

LogP:0.87090

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,9-diazaspiro[5.5]undecan-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,9-diazaspiro[5.5]undecan-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,9-diazaspiro[5.5]undecan-1-one Use and application,2,9-diazaspiro[5.5]undecan-1-one technical grade,usp/ep/jp grade.

Related News: At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. 2,9-diazaspiro[5.5]undecan-1-one manufacturer At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. 2,9-diazaspiro[5.5]undecan-1-one supplier INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 2,9-diazaspiro[5.5]undecan-1-one vendor The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 2,9-diazaspiro[5.5]undecan-1-one factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.